December 08, 2020Resident & Fellow Section
SARS-CoV-2 infection of the CNS in a patient with meningeosis carcinomatosa
Philipp A. Steininger, Frank Seifert, Stefanie Balk, Joji Kuramatsu, Andreas E. Kremer, Roland Coras, Tobias Engelhorn, Clara Maier, Matthias Tenbusch, Klaus Korn, Armin Ensser
First published December 8, 2020, DOI: https://doi.org/10.1212/WNL.0000000000011357
Philipp A. Steininger
Philipp A. Steininger, Institute of Clinical and Molecular Virology, University Hospital of Erlangen, Friedrich-Alexander University Erlangen-Nürnberg (FAU), Erlangen, Germany; Frank Seifert, Department of Neurology, University Hospital of Erlangen, Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany; Stefanie Balk, Department of Neurology, University Hospital of Erlangen, Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany; Joji Kuramatsu, Department of Neurology, University Hospital of Erlangen, Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany; Andreas E. Kremer, Department of Medicine 1, University Hospital of Erlangen, Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany; Roland Coras, Department of Neuropathology, University Hospital of Erlangen, Friedrich-Alexander-Universität ErlangenNürnberg (FAU), Erlangen, Germany; Tobias Engelhorn, Department of Neuroradiology, University Hospital of Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany; Clara Maier, Institute of Clinical and Molecular Virology, University Hospital of Erlangen, Friedrich-Alexander University ErlangenNürnberg (FAU), Erlangen, Germany; Matthias Tenbusch, Institute of Clinical and Molecular Virology, University Hospital of Erlangen, Friedrich-Alexander University Erlangen-Nürnberg (FAU), Erlangen, Germany; Klaus Korn, Institute of Clinical and Molecular Virology, University Hospital of Erlangen, Friedrich-Alexander University Erlangen-Nürnberg (FAU), Erlangen, Germany; Armin Ensser, Institute of Clinical and Molecular Virology, University Hospital of Erlangen, Friedrich-Alexander University Erlangen-Nürnberg (FAU), Erlangen, Germany
Frank Seifert
Philipp A. Steininger, Institute of Clinical and Molecular Virology, University Hospital of Erlangen, Friedrich-Alexander University Erlangen-Nürnberg (FAU), Erlangen, Germany; Frank Seifert, Department of Neurology, University Hospital of Erlangen, Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany; Stefanie Balk, Department of Neurology, University Hospital of Erlangen, Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany; Joji Kuramatsu, Department of Neurology, University Hospital of Erlangen, Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany; Andreas E. Kremer, Department of Medicine 1, University Hospital of Erlangen, Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany; Roland Coras, Department of Neuropathology, University Hospital of Erlangen, Friedrich-Alexander-Universität ErlangenNürnberg (FAU), Erlangen, Germany; Tobias Engelhorn, Department of Neuroradiology, University Hospital of Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany; Clara Maier, Institute of Clinical and Molecular Virology, University Hospital of Erlangen, Friedrich-Alexander University ErlangenNürnberg (FAU), Erlangen, Germany; Matthias Tenbusch, Institute of Clinical and Molecular Virology, University Hospital of Erlangen, Friedrich-Alexander University Erlangen-Nürnberg (FAU), Erlangen, Germany; Klaus Korn, Institute of Clinical and Molecular Virology, University Hospital of Erlangen, Friedrich-Alexander University Erlangen-Nürnberg (FAU), Erlangen, Germany; Armin Ensser, Institute of Clinical and Molecular Virology, University Hospital of Erlangen, Friedrich-Alexander University Erlangen-Nürnberg (FAU), Erlangen, Germany
Roles: Professor
Stefanie Balk
Philipp A. Steininger, Institute of Clinical and Molecular Virology, University Hospital of Erlangen, Friedrich-Alexander University Erlangen-Nürnberg (FAU), Erlangen, Germany; Frank Seifert, Department of Neurology, University Hospital of Erlangen, Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany; Stefanie Balk, Department of Neurology, University Hospital of Erlangen, Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany; Joji Kuramatsu, Department of Neurology, University Hospital of Erlangen, Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany; Andreas E. Kremer, Department of Medicine 1, University Hospital of Erlangen, Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany; Roland Coras, Department of Neuropathology, University Hospital of Erlangen, Friedrich-Alexander-Universität ErlangenNürnberg (FAU), Erlangen, Germany; Tobias Engelhorn, Department of Neuroradiology, University Hospital of Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany; Clara Maier, Institute of Clinical and Molecular Virology, University Hospital of Erlangen, Friedrich-Alexander University ErlangenNürnberg (FAU), Erlangen, Germany; Matthias Tenbusch, Institute of Clinical and Molecular Virology, University Hospital of Erlangen, Friedrich-Alexander University Erlangen-Nürnberg (FAU), Erlangen, Germany; Klaus Korn, Institute of Clinical and Molecular Virology, University Hospital of Erlangen, Friedrich-Alexander University Erlangen-Nürnberg (FAU), Erlangen, Germany; Armin Ensser, Institute of Clinical and Molecular Virology, University Hospital of Erlangen, Friedrich-Alexander University Erlangen-Nürnberg (FAU), Erlangen, Germany
Joji Kuramatsu
Philipp A. Steininger, Institute of Clinical and Molecular Virology, University Hospital of Erlangen, Friedrich-Alexander University Erlangen-Nürnberg (FAU), Erlangen, Germany; Frank Seifert, Department of Neurology, University Hospital of Erlangen, Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany; Stefanie Balk, Department of Neurology, University Hospital of Erlangen, Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany; Joji Kuramatsu, Department of Neurology, University Hospital of Erlangen, Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany; Andreas E. Kremer, Department of Medicine 1, University Hospital of Erlangen, Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany; Roland Coras, Department of Neuropathology, University Hospital of Erlangen, Friedrich-Alexander-Universität ErlangenNürnberg (FAU), Erlangen, Germany; Tobias Engelhorn, Department of Neuroradiology, University Hospital of Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany; Clara Maier, Institute of Clinical and Molecular Virology, University Hospital of Erlangen, Friedrich-Alexander University ErlangenNürnberg (FAU), Erlangen, Germany; Matthias Tenbusch, Institute of Clinical and Molecular Virology, University Hospital of Erlangen, Friedrich-Alexander University Erlangen-Nürnberg (FAU), Erlangen, Germany; Klaus Korn, Institute of Clinical and Molecular Virology, University Hospital of Erlangen, Friedrich-Alexander University Erlangen-Nürnberg (FAU), Erlangen, Germany; Armin Ensser, Institute of Clinical and Molecular Virology, University Hospital of Erlangen, Friedrich-Alexander University Erlangen-Nürnberg (FAU), Erlangen, Germany
Andreas E. Kremer
Philipp A. Steininger, Institute of Clinical and Molecular Virology, University Hospital of Erlangen, Friedrich-Alexander University Erlangen-Nürnberg (FAU), Erlangen, Germany; Frank Seifert, Department of Neurology, University Hospital of Erlangen, Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany; Stefanie Balk, Department of Neurology, University Hospital of Erlangen, Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany; Joji Kuramatsu, Department of Neurology, University Hospital of Erlangen, Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany; Andreas E. Kremer, Department of Medicine 1, University Hospital of Erlangen, Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany; Roland Coras, Department of Neuropathology, University Hospital of Erlangen, Friedrich-Alexander-Universität ErlangenNürnberg (FAU), Erlangen, Germany; Tobias Engelhorn, Department of Neuroradiology, University Hospital of Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany; Clara Maier, Institute of Clinical and Molecular Virology, University Hospital of Erlangen, Friedrich-Alexander University ErlangenNürnberg (FAU), Erlangen, Germany; Matthias Tenbusch, Institute of Clinical and Molecular Virology, University Hospital of Erlangen, Friedrich-Alexander University Erlangen-Nürnberg (FAU), Erlangen, Germany; Klaus Korn, Institute of Clinical and Molecular Virology, University Hospital of Erlangen, Friedrich-Alexander University Erlangen-Nürnberg (FAU), Erlangen, Germany; Armin Ensser, Institute of Clinical and Molecular Virology, University Hospital of Erlangen, Friedrich-Alexander University Erlangen-Nürnberg (FAU), Erlangen, Germany
Roland Coras
Philipp A. Steininger, Institute of Clinical and Molecular Virology, University Hospital of Erlangen, Friedrich-Alexander University Erlangen-Nürnberg (FAU), Erlangen, Germany; Frank Seifert, Department of Neurology, University Hospital of Erlangen, Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany; Stefanie Balk, Department of Neurology, University Hospital of Erlangen, Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany; Joji Kuramatsu, Department of Neurology, University Hospital of Erlangen, Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany; Andreas E. Kremer, Department of Medicine 1, University Hospital of Erlangen, Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany; Roland Coras, Department of Neuropathology, University Hospital of Erlangen, Friedrich-Alexander-Universität ErlangenNürnberg (FAU), Erlangen, Germany; Tobias Engelhorn, Department of Neuroradiology, University Hospital of Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany; Clara Maier, Institute of Clinical and Molecular Virology, University Hospital of Erlangen, Friedrich-Alexander University ErlangenNürnberg (FAU), Erlangen, Germany; Matthias Tenbusch, Institute of Clinical and Molecular Virology, University Hospital of Erlangen, Friedrich-Alexander University Erlangen-Nürnberg (FAU), Erlangen, Germany; Klaus Korn, Institute of Clinical and Molecular Virology, University Hospital of Erlangen, Friedrich-Alexander University Erlangen-Nürnberg (FAU), Erlangen, Germany; Armin Ensser, Institute of Clinical and Molecular Virology, University Hospital of Erlangen, Friedrich-Alexander University Erlangen-Nürnberg (FAU), Erlangen, Germany
Tobias Engelhorn
Philipp A. Steininger, Institute of Clinical and Molecular Virology, University Hospital of Erlangen, Friedrich-Alexander University Erlangen-Nürnberg (FAU), Erlangen, Germany; Frank Seifert, Department of Neurology, University Hospital of Erlangen, Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany; Stefanie Balk, Department of Neurology, University Hospital of Erlangen, Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany; Joji Kuramatsu, Department of Neurology, University Hospital of Erlangen, Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany; Andreas E. Kremer, Department of Medicine 1, University Hospital of Erlangen, Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany; Roland Coras, Department of Neuropathology, University Hospital of Erlangen, Friedrich-Alexander-Universität ErlangenNürnberg (FAU), Erlangen, Germany; Tobias Engelhorn, Department of Neuroradiology, University Hospital of Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany; Clara Maier, Institute of Clinical and Molecular Virology, University Hospital of Erlangen, Friedrich-Alexander University ErlangenNürnberg (FAU), Erlangen, Germany; Matthias Tenbusch, Institute of Clinical and Molecular Virology, University Hospital of Erlangen, Friedrich-Alexander University Erlangen-Nürnberg (FAU), Erlangen, Germany; Klaus Korn, Institute of Clinical and Molecular Virology, University Hospital of Erlangen, Friedrich-Alexander University Erlangen-Nürnberg (FAU), Erlangen, Germany; Armin Ensser, Institute of Clinical and Molecular Virology, University Hospital of Erlangen, Friedrich-Alexander University Erlangen-Nürnberg (FAU), Erlangen, Germany
Roles: Professor
Clara Maier
Philipp A. Steininger, Institute of Clinical and Molecular Virology, University Hospital of Erlangen, Friedrich-Alexander University Erlangen-Nürnberg (FAU), Erlangen, Germany; Frank Seifert, Department of Neurology, University Hospital of Erlangen, Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany; Stefanie Balk, Department of Neurology, University Hospital of Erlangen, Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany; Joji Kuramatsu, Department of Neurology, University Hospital of Erlangen, Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany; Andreas E. Kremer, Department of Medicine 1, University Hospital of Erlangen, Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany; Roland Coras, Department of Neuropathology, University Hospital of Erlangen, Friedrich-Alexander-Universität ErlangenNürnberg (FAU), Erlangen, Germany; Tobias Engelhorn, Department of Neuroradiology, University Hospital of Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany; Clara Maier, Institute of Clinical and Molecular Virology, University Hospital of Erlangen, Friedrich-Alexander University ErlangenNürnberg (FAU), Erlangen, Germany; Matthias Tenbusch, Institute of Clinical and Molecular Virology, University Hospital of Erlangen, Friedrich-Alexander University Erlangen-Nürnberg (FAU), Erlangen, Germany; Klaus Korn, Institute of Clinical and Molecular Virology, University Hospital of Erlangen, Friedrich-Alexander University Erlangen-Nürnberg (FAU), Erlangen, Germany; Armin Ensser, Institute of Clinical and Molecular Virology, University Hospital of Erlangen, Friedrich-Alexander University Erlangen-Nürnberg (FAU), Erlangen, Germany
Matthias Tenbusch
Philipp A. Steininger, Institute of Clinical and Molecular Virology, University Hospital of Erlangen, Friedrich-Alexander University Erlangen-Nürnberg (FAU), Erlangen, Germany; Frank Seifert, Department of Neurology, University Hospital of Erlangen, Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany; Stefanie Balk, Department of Neurology, University Hospital of Erlangen, Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany; Joji Kuramatsu, Department of Neurology, University Hospital of Erlangen, Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany; Andreas E. Kremer, Department of Medicine 1, University Hospital of Erlangen, Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany; Roland Coras, Department of Neuropathology, University Hospital of Erlangen, Friedrich-Alexander-Universität ErlangenNürnberg (FAU), Erlangen, Germany; Tobias Engelhorn, Department of Neuroradiology, University Hospital of Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany; Clara Maier, Institute of Clinical and Molecular Virology, University Hospital of Erlangen, Friedrich-Alexander University ErlangenNürnberg (FAU), Erlangen, Germany; Matthias Tenbusch, Institute of Clinical and Molecular Virology, University Hospital of Erlangen, Friedrich-Alexander University Erlangen-Nürnberg (FAU), Erlangen, Germany; Klaus Korn, Institute of Clinical and Molecular Virology, University Hospital of Erlangen, Friedrich-Alexander University Erlangen-Nürnberg (FAU), Erlangen, Germany; Armin Ensser, Institute of Clinical and Molecular Virology, University Hospital of Erlangen, Friedrich-Alexander University Erlangen-Nürnberg (FAU), Erlangen, Germany
Roles: Professor
Klaus Korn
Philipp A. Steininger, Institute of Clinical and Molecular Virology, University Hospital of Erlangen, Friedrich-Alexander University Erlangen-Nürnberg (FAU), Erlangen, Germany; Frank Seifert, Department of Neurology, University Hospital of Erlangen, Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany; Stefanie Balk, Department of Neurology, University Hospital of Erlangen, Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany; Joji Kuramatsu, Department of Neurology, University Hospital of Erlangen, Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany; Andreas E. Kremer, Department of Medicine 1, University Hospital of Erlangen, Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany; Roland Coras, Department of Neuropathology, University Hospital of Erlangen, Friedrich-Alexander-Universität ErlangenNürnberg (FAU), Erlangen, Germany; Tobias Engelhorn, Department of Neuroradiology, University Hospital of Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany; Clara Maier, Institute of Clinical and Molecular Virology, University Hospital of Erlangen, Friedrich-Alexander University ErlangenNürnberg (FAU), Erlangen, Germany; Matthias Tenbusch, Institute of Clinical and Molecular Virology, University Hospital of Erlangen, Friedrich-Alexander University Erlangen-Nürnberg (FAU), Erlangen, Germany; Klaus Korn, Institute of Clinical and Molecular Virology, University Hospital of Erlangen, Friedrich-Alexander University Erlangen-Nürnberg (FAU), Erlangen, Germany; Armin Ensser, Institute of Clinical and Molecular Virology, University Hospital of Erlangen, Friedrich-Alexander University Erlangen-Nürnberg (FAU), Erlangen, Germany
Armin Ensser
Philipp A. Steininger, Institute of Clinical and Molecular Virology, University Hospital of Erlangen, Friedrich-Alexander University Erlangen-Nürnberg (FAU), Erlangen, Germany; Frank Seifert, Department of Neurology, University Hospital of Erlangen, Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany; Stefanie Balk, Department of Neurology, University Hospital of Erlangen, Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany; Joji Kuramatsu, Department of Neurology, University Hospital of Erlangen, Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany; Andreas E. Kremer, Department of Medicine 1, University Hospital of Erlangen, Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany; Roland Coras, Department of Neuropathology, University Hospital of Erlangen, Friedrich-Alexander-Universität ErlangenNürnberg (FAU), Erlangen, Germany; Tobias Engelhorn, Department of Neuroradiology, University Hospital of Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany; Clara Maier, Institute of Clinical and Molecular Virology, University Hospital of Erlangen, Friedrich-Alexander University ErlangenNürnberg (FAU), Erlangen, Germany; Matthias Tenbusch, Institute of Clinical and Molecular Virology, University Hospital of Erlangen, Friedrich-Alexander University Erlangen-Nürnberg (FAU), Erlangen, Germany; Klaus Korn, Institute of Clinical and Molecular Virology, University Hospital of Erlangen, Friedrich-Alexander University Erlangen-Nürnberg (FAU), Erlangen, Germany; Armin Ensser, Institute of Clinical and Molecular Virology, University Hospital of Erlangen, Friedrich-Alexander University Erlangen-Nürnberg (FAU), Erlangen, Germany
Roles: Professor
SARS-CoV-2 infection of the CNS in a patient with meningeosis carcinomatosa
Philipp A. Steininger, Frank Seifert, Stefanie Balk, Joji Kuramatsu, Andreas E. Kremer, Roland Coras, Tobias Engelhorn, Clara Maier, Matthias Tenbusch, Klaus Korn, Armin Ensser
Neurology Dec 2020, 10.1212/WNL.0000000000011357; DOI: 10.1212/WNL.0000000000011357
Citation Manager Formats
Make Comment
See Comments


This is a PDF-only article. The first page of the PDF of this article appears above.
Disputes & Debates: Rapid online correspondence
No comments have been published for this article.
NOTE: All authors' disclosures must be entered and current in our database before comments can be posted. Enter and update disclosures at http://submit.neurology.org. Exception: replies to comments concerning an article you originally authored do not require updated disclosures.
- Stay timely. Submit only on articles published within the last 8 weeks.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- 200 words maximum.
- 5 references maximum. Reference 1 must be the article on which you are commenting.
- 5 authors maximum. Exception: replies can include all original authors of the article.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Advertisement
Related Articles
- No related articles found.